Zydus Cadila gets USFDA nod to Fluphenazine Hydrochloride Tablets Ruchika Sharma30 May 2021 9:30 AM ISTAhmedabad: Drugmaker, Zydus Cadila, has recently announced that the company has received final approval from the USFDA to market Fluphenazine...
Master transmitter Glutamate: JAMA study hints at new therapeutic targets for schizophrenia Dr. Shivi Kataria29 April 2021 9:54 PM ISTGlutamatergic dysfunction is implicated in the pathophysiology of schizophrenia, but the nature of this dysfunction may change over the course of...
Injectable antipsychotics better than oral ones at preventing relapse in schizophrenia: Lancet Dr Satabdi Saha21 April 2021 8:30 AM ISTIn a recent development, researchers have noted that, among long-acting injectable antipsychotics (LAIs) and oral antipsychotics in managing...
Insomnia linked to suicidal thoughts in schizophrenia,finds study Dr Satabdi Saha1 April 2021 9:30 AM ISTA recent research reort has confirmed that Insomnia is associated with suicidal ideation, recent suicide attempt, and greater psychopathology in...
Peeking into the shadows of negative symptoms: Avolition plays the lead role? Dr. Shivi Kataria26 March 2021 9:00 PM ISTNegative symptoms are one of the most difficult to treat traits of psychiatric disorders. This calls for a better understanding of their mechanisms...
Redefining real-life functioning in Schizophrenia, study highlights the role of neurocognition Dr. Shivi Kataria26 Feb 2021 6:30 AM ISTSchizophrenia is no longer conceptualized as a progressive deteriorating illness. The clinical stability with persistent symptomatic remission is...
Seeing schizophrenia: X-rays shed light on neural differences, point toward treatment Hina Zahid24 Feb 2021 9:30 AM ISTSchizophrenia, a chronic, neurological brain disorder, affects millions of people around the world. It causes a fracture between a person's thoughts,...
Liraglutide effective for Weight loss in Patients With Severe Mental Illness MD Bureau12 Feb 2021 7:48 PM ISTThe prevalence of overweight and obesity is 2-3 times higher among people with schizophrenia than in the general population. In a recent study,...
Clozapine effective option for violent schizophrenia patients with conduct disorder Dr. Nandita Mohan3 Feb 2021 10:15 PM ISTIt has been recently observed by the researchers from the Department of Psychiatry, Nathan Kline Institute for Psychiatric Research, Orangeburg, N.Y....
Increased risk of Parkinson's disease in patients with schizophrenia Hina Zahid19 Jan 2021 5:00 PM ISTA new study conducted at the University of Turku, Finland, shows that patients with a schizophrenia spectrum disorder have an increased risk of...
Early on use of Long-acting antipsychotics reduces hospitalization risk in schizophrenia: JAMA Medha Baranwal14 Dec 2020 12:12 PM ISTNew York: Long-acting injectable antipsychotics (LAIs) treatment should be considered more broadly for the treatment of early-phase...
Indoco Remedies gets USFDA nod to Olanzapine Tablets to treat schizophrenia, bipolar disorder Ruchika Sharma9 Aug 2020 9:30 AM ISTMumbai: Indoco Remedies has recently announced receipt of approval for its ANDA for Olanzapine Tablets USP 2.5mg, 5mg, 7.5 mg, 10mg, 15mg and 20...
